DOI QR코드

DOI QR Code

Biochemical Analysis of Interaction between Kringle Domains of Plasminogen and Prion Proteins with Q167R Mutation

  • Lee, Jeongmin (Division of Zoonoses, Center for Immunology and Pathology, National Institute of Health, Korea Centers for Disease Control and Prevention) ;
  • Lee, Byoung Woo (Department of Genetic Engineering, Sungkyunkwan University) ;
  • Kang, Hae-Eun (Division of Foreign Animal Disease, Animal and Plant Quarantine Agency) ;
  • Choe, Kevine K. (Department of Pharmacy and Institute of Pharmaceutical Science and Technology, Hanyang University) ;
  • Kwon, Moosik (Department of Genetic Engineering, Sungkyunkwan University) ;
  • Ryou, Chongsuk (Department of Pharmacy and Institute of Pharmaceutical Science and Technology, Hanyang University)
  • Received : 2017.02.13
  • Accepted : 2017.03.08
  • Published : 2017.05.28

Abstract

The conformational change of cellular prion protein ($PrP^C$) to its misfolded counterpart, termed $PrP^{Sc}$, is mediated by a hypothesized cellular cofactor. This cofactor is believed to interact directly with certain amino acid residues of $PrP^C$. When these are mutated into cationic amino acid residues, $PrP^{Sc}$ formation and prion replication halt in a dominant negative (DN) manner, presumably due to strong binding of the cofactor to mutated $PrP^C$, designated as DN PrP mutants. Previous studies demonstrated that plasminogen and its kringle domains bind to PrP and accelerate $PrP^{Sc}$ generation. In this study, in vitro binding analysis of kringle domains of plasminogen to Q167R DN mutant PrP (PrPQ167R) was performed in parallel with the wild type (WT) and Q218K DN mutant PrP (PrPQ218K). The binding affinity of PrPQ167R was higher than that of WT PrP, but lower than that of PrPQ218K. Scatchard analysis further indicated that, like PrPQ218K and WT PrP, PrPQ167R interaction with plasminogen occurred at multiple sites, suggesting cooperativity in this interaction. Competitive binding analysis using $\small{L}$-lysine or $\small{L}$-arginine confirmed the increase of the specificity and binding affinity of the interaction as PrP acquired DN mutations. Circular dichroism spectroscopy demonstrated that the recombinant PrPs used in this study retained the ${\alpha}$-helix-rich structure. The ${\alpha}$-helix unfolding study revealed similar conformational stability for WT and DN-mutated PrPs. This study provides an additional piece of biochemical evidence concerning the interaction of plasminogen with DN mutant PrPs.

Keywords

References

  1. Prusiner SB. 1998. Prions. Proc. Natl. Acad. Sci. USA 95: 13363-13383. https://doi.org/10.1073/pnas.95.23.13363
  2. Prusiner SB. 1991. Molecular biology of prion diseases. Science 252: 1515-1522. https://doi.org/10.1126/science.1675487
  3. Rogers M, Yehiely F, Scott M, Prusiner SB. 1993. Conversion of truncated and elongated prion proteins into the scrapie isoform in cultured cells. Proc. Natl. Acad. Sci. USA 90: 3182- 3186. https://doi.org/10.1073/pnas.90.8.3182
  4. Cohen FE, Pan K-M, Huang Z, Baldwin M, Fletterick RJ, Prusiner SB. 1994. Structural clues to prion replication. Science 264: 530-531. https://doi.org/10.1126/science.7909169
  5. Telling GC, Scott M, Mastrianni J, Gabizon R, Torchia M, Cohen FE, et al. 1995. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 83: 79-90. https://doi.org/10.1016/0092-8674(95)90236-8
  6. Kaneko K, Zulianello L, Scott M, Cooper CM, Wallace AC, James TL, et al. 1997. Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. Proc. Natl. Acad. Sci. USA 94: 10069-10074. https://doi.org/10.1073/pnas.94.19.10069
  7. Peretz D, Williamson RA, Matsunaga Y, Serban H, Pinilla C, Bastidas RB, et al. 1997. A conformational transition at the N-terminus of the prion protein features in formation of the scrapie isoform. J. Mol. Biol. 273: 614-622. https://doi.org/10.1006/jmbi.1997.1328
  8. Zulianello L, Kaneko K, Scott M, Erpel S, Han D, Cohen FE, et al. 2000. Dominant-negative inhibition of prion formation diminished by deletion mutagenesis of the prion protein. J. Virol. 74: 4351-4360. https://doi.org/10.1128/JVI.74.9.4351-4360.2000
  9. Mays CE, Ryou C. 2011. Plasminogen: a cellular protein cofactor for PrPSc propagation. Prion 5: 22-27. https://doi.org/10.4161/pri.5.1.14460
  10. Cohen FE, Prusiner SB. 1998. Pathologic conformations of prion proteins. Annu. Rev. Biochem. 67: 793-819. https://doi.org/10.1146/annurev.biochem.67.1.793
  11. Perrier V, Wallace AC, Kaneko K, Safar J, Prusiner SB, Cohen FE. 2000. Mimicking dominant negative inhibition of prion replication through structure-based drug design. Proc. Natl. Acad. Sci. USA 97: 6073-6078. https://doi.org/10.1073/pnas.97.11.6073
  12. Deleault NR, Piro JR, Walsh DJ, Wang F, Ma J, Geoghegan JC, et al. 2012. Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids. Proc. Natl. Acad. Sci. USA 109: 8546-8551. https://doi.org/10.1073/pnas.1204498109
  13. Ryou C. 2007. Prions and prion diseases: fundamentals and mechanistic details. J. Microbiol. Biotechnol. 17: 1059-1070.
  14. Mays CE, Ryou C. 2010. Plasminogen stimulates propagation of protease-resistant prion protein in vitro. FASEB J. 24: 5102-5112. https://doi.org/10.1096/fj.10-163600
  15. Fischer MB, Roeckl C, Parizek P, Schwarz HP, Aguzzi A. 2000. Binding of disease-associated prion protein to plasminogen. Nature 408: 479-483. https://doi.org/10.1038/35044100
  16. Ryou C, Prusiner SB, Legname G. 2003. Cooperative binding of dominant-negative prion protein to kringle domains. J. Mol. Biol. 329: 323-333. https://doi.org/10.1016/S0022-2836(03)00342-5
  17. Maissen M, Roeckl C, Glatzel M, Goldmann W, Aguzzi A. 2001. Plasminogen binds to disease-associated prion protein of multiple species. Lancet 357: 2026-2028. https://doi.org/10.1016/S0140-6736(00)05110-2
  18. Negredo C, Monks E, Sweeney T. 2007. A novel real-time ultrasonic method for prion protein detection using plasminogen as a capture molecule. BMC Biotechnol. 7: 43. https://doi.org/10.1186/1472-6750-7-43
  19. Perrier V, Kaneko K, Safar J, Vergara J, Tremblay P, DeArmond SJ, et al. 2002. Dominant-negative inhibition of prion replication in transgenic mice. Proc. Natl. Acad. Sci. USA 99: 13079-13084. https://doi.org/10.1073/pnas.182425299
  20. Shaked Y, Engelstein R, Gabizon R. 2002. The binding of prion proteins to serum components is affected by detergent extraction conditions. J. Neurochem. 82: 1-5. https://doi.org/10.1046/j.1471-4159.2002.00995.x
  21. Shin W, Lee B, Hong S, Ryou C, Kwon M. 2008. Cloning and expression of a prion protein (PrP) gene from Korean bovine (Bos taurus coreanae) and production of rabbit antibovine PrP antibody. Biotechnol. Lett. 30: 1705-1711. https://doi.org/10.1007/s10529-008-9768-4
  22. Warrens AN, Jones MD, Lechler RI. 1997. Splicing by overlap extension by PCR using asymmetric amplification: an improved technique for the generation of hybrid proteins of immunological interest. Gene 186: 29-35. https://doi.org/10.1016/S0378-1119(96)00674-9
  23. Mehlhorn I, Groth D, Stockel J, Moffat B, Reilly D, Yansura D, et al. 1996. High-level expression and characterization of a purified 142-residue polypeptide of the prion protein. Biochemistry 35: 5528-5537. https://doi.org/10.1021/bi952965e
  24. Kuwajima K. 1995. Circular dichroism, pp. 115-135. In Shirley BA (ed.). Methods in Molecular Biology: Protein Stability and Folding: Theory and Practice. Humana Press, Totowa. USA.
  25. Choi BR, Lee J, Kim SY, Yim I, Kim EH, Woo HJ. 2013. Prion protein conversion induced by trivalent iron in vesicular trafficking. Biochem. Biophys. Res. Commun. 432: 539-544. https://doi.org/10.1016/j.bbrc.2013.02.021
  26. Scatchard G. 1949. The attractions of proteins for small molecules and ions. Ann. N. Y. Acad. Sci. 51: 660-672. https://doi.org/10.1111/j.1749-6632.1949.tb27297.x
  27. Goldmann W, Hunter N, Smith G, Foster J, Hope J. 1994. PrP genotype and agent effects in scrapie: change in allelic interaction with different isolates of agent in sheep, a natural host of scrapie. J. Gen. Virol. 75: 989-995. https://doi.org/10.1099/0022-1317-75-5-989
  28. Westaway D, Zuliani V, Cooper CM, Da Costa M, Neuman S, Jenny AL, et al. 1994. Homozygosity for prion protein alleles encoding glutamine-171 renders sheep susceptible to natural scrapie. Genes Dev. 8: 959-969. https://doi.org/10.1101/gad.8.8.959
  29. Clousard C, Beaudry P, Elsen JM, Milan D, Dussaucy M, Bounneau C, et al. 1995. Different allelic effects of the codons 136 and 171 of the prion protein gene in sheep with natural scrapie. J. Gen. Virol. 76: 2097-2101. https://doi.org/10.1099/0022-1317-76-8-2097
  30. Bossers A, Schreuder BE, Muileman IH, Belt PB, Smits MA. 1996. PrP genotype contributes to determining survival times of sheep with natural scrapie. J. Gen. Virol. 77: 2669-2673. https://doi.org/10.1099/0022-1317-77-10-2669
  31. Hunter N, Moore L, Hosie BD, Dingwall WS, Greig A. 1997. Association between natural scrapie and PrP genotype in a flock of Suffolk sheep in Scotland. Vet. Rec. 140: 59-63. https://doi.org/10.1136/vr.140.3.59
  32. Belt PB, Muileman IH, Schreuder BEC, Ruijter JB, Gielkens ALJ, Smits MA. 1995. Identification of five allelic variants of the sheep PrP gene and their association with natural scrapie. J. Gen. Virol. 76: 509-517. https://doi.org/10.1099/0022-1317-76-3-509
  33. Shibuya S, Higuchi J, Shin R-W, Tateishi J, Kitamoto T. 1998. Protective prion protein polymorphisms against sporadic Creutzfeldt-Jakob disease. Lancet 351: 419.
  34. Shibuya S, Higuchi J, Shin R-W, Tateishi J, Kitamoto T. 1998. Codon 219 Lys allele of PRNP is not found in sporadic Creutzfeldt-Jakob disease. Ann. Neurol. 43: 826-828. https://doi.org/10.1002/ana.410430618
  35. Striebel JF, Race B, Meade-White KD, LaCasse R, Chesebro B. 2011. Strain specific resistance to murine scrapie associated with a naturally occurring human prion protein polymorphism at residue 171. PLoS Pathog. 7: e1002275. https://doi.org/10.1371/journal.ppat.1002275